Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Asia Deal Watch: Genexine Teams With KGBio In Immuno-Oncology, COVID-19 Therapy

Feb 18 2021

• By Joseph Haas and Jung Won Shin

Asia Deal Watch

Related Content

Centrient Acquires India’s Astral SteriTech

Sep 19 2025

Lannett Adds NovoLog Biosimilar As It Writes Off $198m Of Value

Feb 10 2021

Avacta/Daewoong’s Joint-Venture AffyXell Paves Way For Next-Generation Stem Cell Therapy

Feb 11 2021

Scynexis Prepares For NDA Filing With Second Phase III Success In VVC

Apr 21 2020

Related Companies

Genexine Inc.

Kalbe Genexine Biologics

I-Mab

Scynexis, Inc.

Hansoh Pharmaceutical Group Company Limited

Cend Therapeutics, Inc.

Qilu Pharmaceutical Co., Ltd.

Apollomics, Inc.

Edison Oncology Holding Corp.

Iterion Therapeutics, Inc.

Nuance Pharma

Tyg Oncology Ltd.

Aerami Therapeutics

Hangzhou Chance Pharmaceuticals Co. Ltd.

Vectura Group plc

Antibe Therapeutics, Inc.

Ildong Pharmaceutical Co., Ltd.

Arbormed Pharmaceuticals, Inc.

Additional Topics

Asia Pacific Deals Business Strategies Commercial BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.